Grant: CAG/CIHR Fellowship for Research in Gastroenterology/Nutrition
University of Calgary
$60,000.00
Enteric glial P2X7 receptors in inflammatory bowel disease
EF 2008-09
Résumé
Inflammatory bowel disease (IBD) is increasingly prevalent and approximately 10,000 new cases are diagnosed in Canada every year. While the underlying mechanisms causing IBD are unknown, recent advances demonstrate that the enteric nervous system (ENS) plays a key role. In the central nervous system (CNS), glial cells are critical mediators of inflammation. During pathological conditions, astrocytes and microglia release excitatory amino acids, ATP, and proinflammatory cytokines such as interleukin-1β through ionotropic purinergic P2X7 receptors (P2X7Rs), causing proinflammatory responses, neurodegeneration, and the development of chronic and neuropathic pain. Like CNS neurons, enteric neurons are surrounded and far outnumbered by a distinct type of peripheral glial cell called enteric glia. Molecular and morphological similarities between enteric glia and CNS astrocytes suggest they fulfill similar roles but the functional role of enteric glia remains largely unknown, although enteric glia have been implicated in the development of intestinal inflammation. We recently discovered that enteric glia are actively involved in purinergic neurotransmission in the ENS. Enteric glia express P2X7Rs but their role in the development of inflammatory conditions in the ENS is unknown. We propose that enteric glia upregulate P2X7R function during inflammation, leading to excitotoxicity in enteric neurons. We will test this hypothesis using calcium imaging and dye uptake assays to investigate if enteric glial P2X7Rs are more functional in inflamed intestines. Further, we will utilize mice deficient in the P2X7 gene (P2X7-KO) and mice administered inhibitors of P2X7Rs to test if modulation of P2X7Rs prevents inflammation-induced neuronal loss. The proposed experiments will significantly add to our comprehension of cellular mechanisms leading to IBD, leading to the development of targeted pharmaceuticals for IBD and increasing the quality of life for thousands of Canadians.
Programme
CAG/CIHR Fellowship for Research in Gastroenterology/Nutrition
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
175659
Name
Gulbransen Brian D
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario); Crohn's and Colitis Canada (Toronto, Ontario)
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
CIHR - INMD - CAG (Canadian Association of Gastroenterology) Partnership
Projecttitle
Enteric glial P2X7 receptors in inflammatory bowel disease
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$60,000
Cihrequipment2
$0
Programname2
CAG/CIHR Fellowship for Research in Gastroenterology/Nutrition
Keyworddelim
Colitis; Enteric; Glia; Guinea Pig; Inflammation; Mouse; Myenteric; Neurodegeneration; P2x7; Purinergic
Abstract
Inflammatory bowel disease (IBD) is increasingly prevalent and approximately 10,000 new cases are diagnosed in Canada every year. While the underlying mechanisms causing IBD are unknown, recent advances demonstrate that the enteric nervous system (ENS) plays a key role. In the central nervous system (CNS), glial cells are critical mediators of inflammation. During pathological conditions, astrocytes and microglia release excitatory amino acids, ATP, and proinflammatory cytokines such as interleukin-1β through ionotropic purinergic P2X7 receptors (P2X7Rs), causing proinflammatory responses, neurodegeneration, and the development of chronic and neuropathic pain. Like CNS neurons, enteric neurons are surrounded and far outnumbered by a distinct type of peripheral glial cell called enteric glia. Molecular and morphological similarities between enteric glia and CNS astrocytes suggest they fulfill similar roles but the functional role of enteric glia remains largely unknown, although enteric glia have been implicated in the development of intestinal inflammation. We recently discovered that enteric glia are actively involved in purinergic neurotransmission in the ENS. Enteric glia express P2X7Rs but their role in the development of inflammatory conditions in the ENS is unknown. We propose that enteric glia upregulate P2X7R function during inflammation, leading to excitotoxicity in enteric neurons. We will test this hypothesis using calcium imaging and dye uptake assays to investigate if enteric glial P2X7Rs are more functional in inflamed intestines. Further, we will utilize mice deficient in the P2X7 gene (P2X7-KO) and mice administered inhibitors of P2X7Rs to test if modulation of P2X7Rs prevents inflammation-induced neuronal loss. The proposed experiments will significantly add to our comprehension of cellular mechanisms leading to IBD, leading to the development of targeted pharmaceuticals for IBD and increasing the quality of life for thousands of Canadians.
Competitiondate
200810
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Gulbransen, Brian D
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $60,000~ $0~